Arbutus Biopharma Corporation
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2011 | -192.9% | -192.9% | — |
| FY2012 | 72.4% | 72.4% | — |
| FY2013 | -23.8% | -23.8% | -19.6% |
| FY2014 | -44.1% | -44.1% | -32.9% |
| FY2015 | -11.5% | -11.5% | -8.8% |
| FY2016 | -189.2% | -189.2% | -139.2% |
| FY2017 | -46.3% | -46.3% | -35.6% |
| FY2018 | -28.5% | -28.5% | -25.0% |
| FY2019 | -211.3% | -211.3% | -145.7% |
| FY2020 | -62.5% | -62.5% | -46.5% |
| FY2021 | -45.0% | -45.0% | -37.3% |
| FY2022 | -50.8% | -50.8% | -35.5% |
| FY2023 | -68.7% | -68.7% | -50.4% |
| FY2024 | -71.8% | -71.8% | -53.1% |
| FY2025 | -43.7% | -43.7% | -35.4% |